University of California | ClinicalTrials HQ

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cognition and Imaging With Tigertriever	brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder	Recruiting	Not stated	2026-10-09		NCT05531461
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-cell acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 1	2026-09-11		NCT04972942
Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, X-linked disease, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, ornithine carbamoyltransferase deficiency, urea cycle disorder	Active, not recruiting	Phase 3	2026-09-09		NCT05345171
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer	Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm	Recruiting	Phase 1	2026-08-10		NCT06823167
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis	Clinical High Risk for Psychosis (CHR)	Recruiting	Phase 1 / Phase 2	2026-06-08		NCT07226895
Human Laboratory Study of Apremilast for Alcohol Use Disorder	Alcohol Use Disorder, Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorder	Recruiting	Phase 2	2026-05-01		NCT07325266
Primary Tumor Research and Outcomes Network	neoplasm	Recruiting	Not stated	2026-02-25		NCT02790983
Stem Cell Therapy for Limbal Stem Cell Deficiency	corneal disorder, eye disorder, limbal stem cell deficiency	Active, not recruiting	Phase 1	2026-02-10		NCT03957954
Fecal Microbiota Transplant National Registry	Bacterial Infections and Mycoses, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections	Recruiting	Not stated	2026-01-21		NCT03325855
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study	Arterial Occlusive Diseases, Cerebral Small Vessel Diseases, Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Leukoencephalopathies, Necrosis, Nerve Degeneration, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, cognitive disorder, dementia, hereditary disease, intracranial arterial disease, intracranial arteriosclerosis, ischemic disease, nervous system disorder, psychiatric disorder, stroke disorder, vascular dementia, vascular disorder	Recruiting	Not stated	2026-01-15		NCT05677880
A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder	Chemically-Induced Disorders, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, alcohol abuse, alcohol-related disorders, anxiety, anxiety disorder, depressive disorder, nervous system disorder, psychiatric disorder, sleep-wake disorder, substance-related disorder	Not yet recruiting	Phase 2	2024-11-29		NCT06710431